Ankylosing Spondylitis

A Phase 3 Randomized, Placebo-Controlled, Double-Blind Program to Evaluate the Efficacy and Safety of Upadacitinib in Adult Subjects with Ankylosing Spondylitis

Sign Up For A Study

Study Information

Condition

Ankylosing Spondylitis

Phase III

Conquest Research needs volunteers for an ankylosing spondylitis trial evaluating a medication designed for the treatment of ankylosing spondylitis. You may qualify if you:

  • Are at least 18 years of age

  • Have a clinical diagnosis of ankylosing spondylitis

Eligible participants will receive study-related care at no cost. Compensation for time and travel may be available. No medical insurance is required for participation.

Sign Up For A Study

    What To Expect

    PATIENT RESOURCES & FAQ

    Conquest Research is partnering with physician practices throughout Central Florida to raise awareness and offer clinical research opportunities to those in need.

    SEE MORE
    A mature medical doctor smiling as some of his colleagues stand in the background

    Register For A Study!

    Register